[10-Q] Avient Corporation Quarterly Earnings Report

Rhea-AI Filing Summary

Avient (AVNT) posted solid Q2-25 results. Sales rose 2.0% YoY to $866.5 million, helped by 1.4 pp FX tailwind and strength in Defense and Healthcare. Gross margin expanded 180 bp to 32.1% as environmental charges eased, lifting operating income 33% to $96.1 million. Net income to common shareholders jumped 56% to $52.6 million and diluted EPS reached $0.57 versus $0.36 a year ago. Interest expense fell 7% on lower term-loan pricing.

Six-month figures are mixed. Sales inched up 0.9% to $1.69 billion but a $71.6 million non-cash impairment and $14.7 million hosting fees tied to the discontinued S/4HANA ERP project cut operating income 42% to $96.8 million and slashed EPS to $0.35 (-61%).

Balance sheet/liquidity: Cash declined to $474.5 million (-$70 million YTD) after $50 million voluntary term-loan prepayment and $49.4 million dividends. Total debt dipped to $2.05 billion; a new $500 million revolving credit facility maturing 2030 replaced the prior 2026 line, leaving $487 million availability and no borrowings outstanding. Net leverage remains above 3× EBITDA (exact ratio not disclosed).

Other highlights: Environmental accruals total $141.3 million, chiefly for the Calvert City barrier-wall project now under construction. The IRS continues to contest a $23.8 million 2019 capital-loss position; no reserve has been recorded. Segment mix improved: Color, Additives & Inks operating profit +5% YoY, while Specialty Engineered Materials -6% on higher maintenance spend. Capex was $39.5 million YTD, trending below prior year.

Positive

• Q2-25 EPS up 56% YoY, reflecting improved mix and lower remediation costs.
• Gross margin widened 180 bp to 32.1%, indicating pricing discipline.
• Reduced leverage: $50 million voluntary term-loan prepayment and lower net debt.
• Credit enhancement: new $500 million revolver extends maturity to 2030 and cut term-loan spread by 25 bp.

Negative

• $71.6 million impairment from cancelled S/4HANA ERP drove 61% drop in H1 EPS.
• Environmental liabilities remain sizable at $141.3 million with cash outflows through 2028.
• IRS dispute over $23.8 million tax deficiency plus penalties could increase effective tax rate and cash taxes.
• Cash balance fell $70 million YTD; free-cash generation remains thin relative to dividend commitment.

Insights

Sell-side Equity Analyst

TL;DR — Q2 beat on earnings and margin; full-year trajectory clouded by ERP write-off and environmental/tax overhang.

Quarterly momentum is encouraging: volume/mix stabilization, FX benefit and lower remediation costs lifted EPS more than 50%. However, the six-month impairment drags FY-25 comparables and signals execution risk in IT strategy. Cash generation remains modest (YTD FCF negative after dividends and capex) but refinancing extends liquidity runway and trims interest by 25 bp. Environmental cash spend accelerates through 2028, and the unresolved $35 million IRS dispute could hit future tax rates. Valuation sensitive investors will weigh improving operating metrics against elevated leverage (~3×) and legacy liabilities.

Credit Analyst

TL;DR — Credit profile stable; term-loan repricing and revolver renewal de-risk near-term maturities.

Gross debt fell $50 million to $2.05 billion and weighted-average coupon dropped as the term loan now carries SOFR+175 bp. Absence of revolver draws and $961 million total liquidity buffer support covenant flexibility. Environmental accruals and ERP impairment are non-cash but highlight contingent outflows. Cross-currency swap liability rose to $380.6 million, yet is offset in AOCI and does not affect cash. With majority of maturities beyond 2029 and interest coverage >4× (based on H1 run-rate), I view the filing as credit neutral to slightly positive.

0001122976false2025Q212/31http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:EURavnt:segmentavnt:company00011229762025-01-012025-06-3000011229762025-06-3000011229762025-04-012025-06-3000011229762024-04-012024-06-3000011229762024-01-012024-06-3000011229762024-12-3100011229762023-12-3100011229762024-06-300001122976us-gaap:CommonStockMember2024-12-310001122976us-gaap:TreasuryStockCommonMember2024-12-310001122976us-gaap:AdditionalPaidInCapitalMember2024-12-310001122976us-gaap:RetainedEarningsMember2024-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001122976us-gaap:ParentMember2024-12-310001122976us-gaap:NoncontrollingInterestMember2024-12-310001122976us-gaap:RetainedEarningsMember2025-01-012025-03-310001122976us-gaap:ParentMember2025-01-012025-03-310001122976us-gaap:NoncontrollingInterestMember2025-01-012025-03-3100011229762025-01-012025-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001122976us-gaap:TreasuryStockCommonMember2025-01-012025-03-310001122976us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001122976us-gaap:CommonStockMember2025-03-310001122976us-gaap:TreasuryStockCommonMember2025-03-310001122976us-gaap:AdditionalPaidInCapitalMember2025-03-310001122976us-gaap:RetainedEarningsMember2025-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001122976us-gaap:ParentMember2025-03-310001122976us-gaap:NoncontrollingInterestMember2025-03-3100011229762025-03-310001122976us-gaap:RetainedEarningsMember2025-04-012025-06-300001122976us-gaap:ParentMember2025-04-012025-06-300001122976us-gaap:NoncontrollingInterestMember2025-04-012025-06-300001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001122976us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001122976us-gaap:TreasuryStockCommonMember2025-04-012025-06-300001122976us-gaap:CommonStockMember2025-06-300001122976us-gaap:TreasuryStockCommonMember2025-06-300001122976us-gaap:AdditionalPaidInCapitalMember2025-06-300001122976us-gaap:RetainedEarningsMember2025-06-300001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001122976us-gaap:ParentMember2025-06-300001122976us-gaap:NoncontrollingInterestMember2025-06-300001122976us-gaap:CommonStockMember2023-12-310001122976us-gaap:TreasuryStockCommonMember2023-12-310001122976us-gaap:AdditionalPaidInCapitalMember2023-12-310001122976us-gaap:RetainedEarningsMember2023-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001122976us-gaap:ParentMember2023-12-310001122976us-gaap:NoncontrollingInterestMember2023-12-310001122976us-gaap:RetainedEarningsMember2024-01-012024-03-310001122976us-gaap:ParentMember2024-01-012024-03-310001122976us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100011229762024-01-012024-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001122976us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001122976us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001122976us-gaap:CommonStockMember2024-03-310001122976us-gaap:TreasuryStockCommonMember2024-03-310001122976us-gaap:AdditionalPaidInCapitalMember2024-03-310001122976us-gaap:RetainedEarningsMember2024-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001122976us-gaap:ParentMember2024-03-310001122976us-gaap:NoncontrollingInterestMember2024-03-3100011229762024-03-310001122976us-gaap:RetainedEarningsMember2024-04-012024-06-300001122976us-gaap:ParentMember2024-04-012024-06-300001122976us-gaap:NoncontrollingInterestMember2024-04-012024-06-300001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001122976us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001122976us-gaap:TreasuryStockCommonMember2024-04-012024-06-300001122976us-gaap:CommonStockMember2024-06-300001122976us-gaap:TreasuryStockCommonMember2024-06-300001122976us-gaap:AdditionalPaidInCapitalMember2024-06-300001122976us-gaap:RetainedEarningsMember2024-06-300001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001122976us-gaap:ParentMember2024-06-300001122976us-gaap:NoncontrollingInterestMember2024-06-300001122976avnt:SpecialtyEngineeredMaterialsMember2024-12-310001122976avnt:ColorAdditivesAndInksMember2024-12-310001122976avnt:SpecialtyEngineeredMaterialsMember2025-01-012025-06-300001122976avnt:ColorAdditivesAndInksMember2025-01-012025-06-300001122976avnt:SpecialtyEngineeredMaterialsMember2025-06-300001122976avnt:ColorAdditivesAndInksMember2025-06-300001122976us-gaap:CustomerRelationshipsMember2025-06-300001122976avnt:PatentsTechnologyAndOtherMember2025-06-300001122976us-gaap:TradeNamesMember2025-06-300001122976us-gaap:CustomerRelationshipsMember2024-12-310001122976avnt:PatentsTechnologyAndOtherMember2024-12-310001122976us-gaap:TradeNamesMember2024-12-310001122976avnt:CloudBasedEnterpriseResourcePlanningSystemImpairmentAndOtherRelatedChargesMember2025-01-012025-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-06-300001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-06-300001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-06-300001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-06-300001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-06-300001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-06-300001122976avnt:ConsolidationOfTwoManufacturingSitesMember2025-04-012025-06-300001122976avnt:ConsolidationOfTwoManufacturingSitesMember2025-01-012025-06-300001122976us-gaap:LandAndLandImprovementsMember2025-06-300001122976us-gaap:LandAndLandImprovementsMember2024-12-310001122976us-gaap:BuildingMember2025-06-300001122976us-gaap:BuildingMember2024-12-310001122976us-gaap:MachineryAndEquipmentMember2025-06-300001122976us-gaap:MachineryAndEquipmentMember2024-12-310001122976us-gaap:InternalRevenueServiceIRSMember2024-12-012024-12-310001122976us-gaap:InternalRevenueServiceIRSMember2025-03-042025-03-040001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2026Member2025-06-300001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2026Member2025-01-012025-06-300001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-06-300001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-01-012025-06-300001122976avnt:A6.25SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2025-06-300001122976avnt:A6.25SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2025-01-012025-06-300001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2025-06-300001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2025-01-012025-06-300001122976us-gaap:OtherDebtSecuritiesMember2025-06-300001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2026Member2024-12-310001122976us-gaap:RevolvingCreditFacilityMemberavnt:RevolvingCreditFacilityDue2026Member2024-01-012024-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-01-012024-12-310001122976avnt:A575SeniorNotesDue2025Memberus-gaap:SeniorNotesMember2024-12-310001122976avnt:A575SeniorNotesDue2025Memberus-gaap:SeniorNotesMember2024-01-012024-12-310001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2024-12-310001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2024-01-012024-12-310001122976us-gaap:OtherDebtSecuritiesMember2024-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-122025-03-120001122976us-gaap:SecuredOvernightFinancingRateSofrMemberavnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-122025-03-120001122976us-gaap:BaseRateMemberavnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-122025-03-120001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-04-012025-06-300001122976us-gaap:RevolvingCreditFacilityMemberavnt:JPMorganChaseBankCreditFacilityMemberus-gaap:LineOfCreditMember2025-06-120001122976avnt:November2026Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-06-300001122976avnt:August2027Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-06-300001122976avnt:January2028Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-06-300001122976avnt:January2029Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-04-012025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-01-012025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2024-04-012024-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2024-01-012024-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-04-012025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-04-012024-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-01-012024-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-06-300001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-04-012025-06-300001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-04-012025-06-300001122976us-gaap:CorporateNonSegmentMember2025-04-012025-06-300001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2024-04-012024-06-300001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2024-04-012024-06-300001122976us-gaap:CorporateNonSegmentMember2024-04-012024-06-300001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-01-012025-06-300001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-01-012025-06-300001122976us-gaap:CorporateNonSegmentMember2025-01-012025-06-300001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2024-01-012024-06-300001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2024-01-012024-06-300001122976us-gaap:CorporateNonSegmentMember2024-01-012024-06-300001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-06-300001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2024-12-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-06-300001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2024-12-310001122976us-gaap:CorporateNonSegmentMember2025-06-300001122976us-gaap:CorporateNonSegmentMember2024-12-310001122976avnt:CalvertCityMember2020-02-012020-02-290001122976avnt:CalvertCityMember2025-06-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________________

FORM 10-Q

________________________________________________

(Mark One)

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2025

OR    

 

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from             to             .

Commission file number 1-16091

 ________________________________________________

AVIENT CORPORATION

(Exact name of registrant as specified in its charter)

________________________________________________

Ohio									34-1730488
(State or other jurisdiction									(I.R.S. Employer Identification No.)
of incorporation or organization)
33587 Walker Road									44012
Avon Lake, Ohio
(Address of principal executive offices)									(Zip Code)

Registrant’s telephone number, including area code: (440) 930-1000

Former name, former address and former fiscal year, if changed since last report: Not Applicable

_______________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Shares, par value $.01 per share			AVNT			New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒    Yes   ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒    Yes   ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer			☒			Accelerated filer			☐
Non-accelerated filer			☐			Smaller reporting company			☐
						Emerging growth company			☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐  Yes   ☒  No

The number of the registrant’s outstanding common shares, par value $.01 per share, as of June 30, 2025 was 91,540,567.

AVIENT CORPORATION

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Avient Corporation

Condensed Consolidated Statements of Income (Unaudited)

(In millions, except per share data)

			Three Months Ended June 30,												Six Months Ended June 30,
			2025						2024						2025						2024
Sales			$	866.5					$	849.7					$	1,693.1					$	1,678.7
Cost of sales			588.6						592.1						1,152.0						1,142.9
Gross margin			277.9						257.6						541.1						535.8
Selling and administrative expense			181.8						185.1						444.3						369.3
Operating income			96.1						72.5						96.8						166.5
Interest expense, net			(24.7)						(26.6)						(51.6)						(53.2)
Other expense, net			(0.5)						(0.9)						(0.9)						(1.8)
Income before income taxes			70.9						45.0						44.3						111.5
Income tax expense			(17.4)						(11.2)						(10.7)						(28.0)
Net income			$	53.5					$	33.8					$	33.6					$	83.5
Net income attributable to noncontrolling interests			(0.9)						(0.2)						(1.2)						(0.5)
Net income attributable to Avient common shareholders			$	52.6					$	33.6					$	32.4					$	83.0
Earnings per share attributable to Avient common shareholders - Basic:			$	0.57					$	0.37					$	0.35					$	0.91
Earnings per share attributable to Avient common shareholders - Diluted:			$	0.57					$	0.36					$	0.35					$	0.90
Weighted-average shares used to compute earnings per common share:
Basic			91.5						91.3						91.5						91.3
Plus dilutive impact of share-based compensation			0.3						0.9						0.3						0.7
Diluted			91.8						92.2						91.8						92.0
Anti-dilutive share-based compensation awards			1.6						0.4						1.5						1.1
Cash dividends declared per share of common stock			$	0.2700					$	0.2575					$	0.5400					$	0.5150

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

1 AVIENT CORPORATION

Avient Corporation

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

(In millions)

			Three Months Ended June 30,												Six Months Ended June 30,
			2025						2024						2025						2024
Net income			$	53.5					$	33.8					$	33.6					$	83.5
Other comprehensive income (loss), net of tax:
Translation adjustments and related hedging instruments			29.4						(18.5)						58.9						(44.4)
Total other comprehensive income (loss)			29.4						(18.5)						58.9						(44.4)
Total comprehensive income			82.9						15.3						92.5						39.1
Comprehensive income attributable to noncontrolling interests			(0.9)						(0.2)						(1.2)						(0.5)
Comprehensive income attributable to Avient common shareholders			$	82.0					$	15.1					$	91.3					$	38.6

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

2 AVIENT CORPORATION

Avient Corporation

Condensed Consolidated Balance Sheets

(In millions)

			(Unaudited) June 30, 2025						December 31, 2024
ASSETS
Current assets:
Cash and cash equivalents			$	474.5					$	544.5
Accounts receivable, net			523.4						399.5
Inventories, net			387.5						346.8
Other current assets			109.0						131.3
Total current assets			1,494.4						1,422.1
Property, net			986.1						955.3
Goodwill			1,754.6						1,659.7
Intangible assets, net			1,529.3						1,450.4
Other non-current assets			368.9						323.6
Total assets			$	6,133.3					$	5,811.1
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt			$	0.5					$	7.7
Accounts payable			439.4						417.4
Accrued expenses and other current liabilities			297.4						331.0
Total current liabilities			737.3						756.1
Non-current liabilities:
Long-term debt			2,020.0						2,059.3
Deferred income taxes			306.9						260.4
Other non-current liabilities			695.1						405.7
Total non-current liabilities			3,022.0						2,725.4
SHAREHOLDERS' EQUITY
Avient shareholders’ equity			2,358.3						2,313.8
Noncontrolling interest			15.7						15.8
Total equity			2,374.0						2,329.6
Total liabilities and equity			$	6,133.3					$	5,811.1

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

3 AVIENT CORPORATION

Avient Corporation

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In millions)

			Six Months Ended June 30,
			2025						2024
Operating activities
Net income			$	33.6					$	83.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			91.9						89.2
Cloud-based enterprise resource planning system impairment			71.6						—
Share-based compensation expense			4.6						9.0
Changes in assets and liabilities:
Increase in accounts receivable			(102.9)						(97.0)
Increase in inventories			(20.8)						(27.3)
Increase in accounts payable			1.4						11.9
Environmental insurance recovery			34.0						—
(Decrease) increase in incentive accruals			(40.6)						5.1
Accrued expenses and other assets and liabilities, net			(11.1)						(11.3)
Net cash provided by operating activities			61.7						63.1
Investing activities
Capital expenditures			(39.5)						(55.8)
Proceeds from plant closures			—						3.4
Other investing activities			—						(2.1)
Net cash used by investing activities			(39.5)						(54.5)
Financing activities
Payments on long-term borrowings			(50.2)						(4.5)
Cash dividends paid			(49.4)						(47.0)
Other financing activities			(6.8)						(3.3)
Net cash used by financing activities			(106.4)						(54.8)
Effect of exchange rate changes on cash			14.2						(10.2)
Decrease in cash and cash equivalents			(70.0)						(56.4)
Cash and cash equivalents at beginning of year			544.5						545.8
Cash and cash equivalents at end of period			$	474.5					$	489.4

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

4 AVIENT CORPORATION

Avient Corporation

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

(In millions)

						Common Shares												Shareholders’ Equity
						Common Shares						Common Shares Held in Treasury						Common Shares						Additional Paid-in Capital						Retained Earnings						Common Shares Held in Treasury						Accumulated Other Comprehensive (Loss) Income						Total Avient Shareholders' Equity						Non-controlling Interests						Total Equity
Balance at January 1, 2025						122.2						(30.8)						$	1.2					$	1,537.5					$	1,882.5					$	(929.6)					$	(177.8)					$	2,313.8					$	15.8					$	2,329.6
Net loss						—						—						—						—						(20.2)						—						—						(20.2)						0.3						(19.9)
Other comprehensive income						—						—						—						—						—						—						29.5						29.5						—						29.5
Cash dividends declared -- $0.2700 per share						—						—						—						—						(24.7)						—						—						(24.7)						—						(24.7)
Share-based compensation and exercise of awards						—						0.1						—						(1.2)						—						1.1						—						(0.1)						—						(0.1)
Balance at March 31, 2025						122.2						(30.7)						$	1.2					$	1,536.3					$	1,837.6					$	(928.5)					$	(148.3)					$	2,298.3					$	16.1					$	2,314.4
Net income						—						—						—						—						52.6						—						—						52.6						0.9						53.5
Other comprehensive income						—						—						—						—						—						—						29.4						29.4						—						29.4
Noncontrolling interest activity						—						—						—						—						—						—						—						—						(1.3)						(1.3)
Cash dividends declared -- $0.2700 per share						—						—						—						—						(24.7)						—						—						(24.7)						—						(24.7)
Share-based compensation and exercise of awards						—						—						—						2.6						—						0.1						—						2.7						—						2.7
Balance at June 30, 2025						122.2						(30.7)						$	1.2					$	1,538.9					$	1,865.5					$	(928.4)					$	(118.9)					$	2,358.3					$	15.7					$	2,374.0

						Common Shares												Shareholders’ Equity
						Common Shares						Common Shares  Held in Treasury						Common Shares						Additional Paid-in Capital						Retained Earnings						Common Shares  Held in Treasury						Accumulated Other Comprehensive (Loss) Income						Total Avient Shareholders' Equity						Non-controlling Interests						Total Equity
Balance at January 1, 2024						122.2						(31.0)						$	1.2					$	1,529.7					$	1,808.2					$	(932.5)					$	(87.4)					$	2,319.2					$	18.8					$	2,338.0
Net income						—						—						—						—						49.4						—						—						49.4						0.3						49.7
Other comprehensive loss						—						—						—						—						—						—						(25.9)						(25.9)						—						(25.9)
Noncontrolling interest activity						—						—						—						0.3												—						—						0.3						(2.6)						(2.3)
Cash dividends declared -- $0.2575 per share						—						—						—						—						(23.5)						—						—						(23.5)						—						(23.5)
Share-based compensation and exercise of awards						—						0.1						—						0.9						—						0.9						—						1.8						—						1.8
Balance at March 31, 2024						122.2						(30.9)						$	1.2					$	1,530.9					$	1,834.1					$	(931.6)					$	(113.3)					$	2,321.3					$	16.5					$	2,337.8
Net income						—						—						—						—						33.6						—						—						33.6						0.2						33.8
Other comprehensive loss						—						—						—						—						—						—						(18.5)						(18.5)						—						(18.5)
Cash dividends declared -- $0.2575 per share						—						—						—						—						(23.5)						—						—						(23.5)						—						(23.5)
Share-based compensation and exercise of awards						—						—						—						3.9						—						0.7						—						4.6						—						4.6
Balance at June 30, 2024						122.2						(30.9)						$	1.2					$	1,534.8					$	1,844.2					$	(930.9)					$	(131.8)					$	2,317.5					$	16.7					$	2,334.2

See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

5 AVIENT CORPORATION

Avient Corporation

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1 — BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Form 10-Q instructions and in the opinion of management contain all adjustments, including those that are normal, recurring and necessary to present fairly the financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the year ended December 31, 2024 of Avient Corporation. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.

Operating results for the three and six months ended June 30, 2025 are not necessarily indicative of the results that may be attained in subsequent periods or for the year ending December 31, 2025.

Accounting Standards Adopted

In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires additional segment disclosures on an annual and interim basis, including significant segment expenses that are regularly provided to the chief operating decision maker. The Company adopted this standard for the year ended December 31, 2024, and interim periods thereafter, and applied retrospective changes to all periods presented in the condensed consolidated financial statements. The adoption of ASU 2023-07 impacted segment disclosures within Note 9, Segment Information.

Accounting Standards Not Yet Adopted

ASU 2023-09, Income Taxes, provides guidance requiring disaggregated income tax disclosures on an annual basis, including information on the Company's effective tax rate reconciliation and income taxes paid. This guidance is effective for fiscal years beginning after December 15, 2024, and may be applied prospectively or retrospectively. The Company is currently evaluating the impacts of adopting this standard to its income taxes disclosures.

ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures, provides guidance requiring disaggregated disclosure of income statement expenses. This guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. This guidance may be applied prospectively or retrospectively. The Company is currently evaluating the impacts of adopting this standard to its financial statement disclosures.

Note 2 — GOODWILL AND INTANGIBLE ASSETS

Goodwill as of June 30, 2025 and December 31, 2024 and changes in the carrying amount of goodwill by segment were as follows:

(In millions)			Specialty Engineered Materials						Color, Additives and Inks												Total
Balance at December 31, 2024			$	656.3					$	1,003.4											$	1,659.7
Currency translation			52.6						42.3												94.9
Balance at June 30, 2025			$	708.9					$	1,045.7											$	1,754.6

6 AVIENT CORPORATION

Indefinite and finite-lived intangible assets consisted of the following:

			As of June 30, 2025
(In millions)			Acquisition Cost						Accumulated Amortization						Currency Translation						Net
Customer relationships			$	726.2					$	(252.0)					$	37.7					$	511.9
Patents, technology and other			847.0						(278.1)						44.9						613.8
Indefinite-lived trade names			362.8						—						40.8						403.6
Total			$	1,936.0					$	(530.1)					$	123.4					$	1,529.3

			As of December 31, 2024
(In millions)			Acquisition Cost						Accumulated Amortization						Currency Translation						Net
Customer relationships			$	726.2					$	(234.9)					$	(0.4)					$	490.9
Patents, technology and other			847.0						(255.8)						(6.1)						585.1
Indefinite-lived trade names			362.8						—						11.6						374.4
Total			$	1,936.0					$	(490.7)					$	5.1					$	1,450.4

Note 3 — RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES

Cloud-based Enterprise Resource Planning System Impairment and Other Related Charges

In the first quarter of 2025, the Company completed a review of its cloud-based enterprise resource planning system, S/4HANA, including updated project timelines, cost incurred to date, required internal resources and expected costs to complete the initial site implementations, and the evolution of options that could provide better returns for shareholders. As a result of this review, the Company determined it would cease the ongoing development of S/4HANA.

As a result of this decision, in the first quarter of 2025, the Company recognized a non-cash, pre-tax impairment charge of $71.6 million associated with capitalized implementation costs. The Company also recognized pre-tax charges of $14.7 million associated with unpaid contractual obligations for hosting fees. Further, the Company recognized charges of $2.8 million associated to severance actions resulting from the decision to cease development of S/4HANA. These charges are included in Selling and administrative expense within the Condensed Consolidated Statements of Income.

Clariant Color Integration Restructuring Program

We are engaged in a restructuring program associated with our integration of Clariant Color. These actions are expected to enable us to better serve customers, improve efficiency and deliver cost savings. We expect that the full restructuring plan will be implemented by the end of 2025 and anticipate that we will incur approximately $70.0 million of charges in connection with the restructuring plan. As of June 30, 2025, $63.8 million had been incurred.

A summary of the Clariant Color integration restructuring is shown below:

(in millions)			Workforce reductions						Plant closing and other						Total
Balance at January 1, 2024			$	30.3					$	0.8					$	31.1
Restructuring charges			0.4						1.6						2.0
Payments, utilization and translation			(23.3)						(1.6)						(24.9)
Balance at December 31, 2024			$	7.4					$	0.8					$	8.2
Restructuring charges			1.4						0.1						1.5
Payments, utilization and translation			(1.9)						(0.1)						(2.0)
Balance at June 30, 2025			$	6.9					$	0.8					$	7.7

Other Restructuring Actions

During the three and six months ended June 30, 2025, the Company recognized charges of $2.6 million and $10.2 million, respectively, primarily associated with plant closure costs and workforce reduction.

7 AVIENT CORPORATION

Note 4 — INVENTORIES, NET

Components of Inventories, net are as follows:

(In millions)			As of June 30, 2025						As of December 31, 2024
Finished products			$	154.7					$	159.2
Work in process			25.8						21.0
Raw materials and supplies			207.0						166.6
Inventories, net			$	387.5					$	346.8

Note 5 — PROPERTY, NET

Components of Property, net are as follows:

(In millions)			As of June 30, 2025						As of December 31, 2024
Land and land improvements			$	101.4					$	93.9
Buildings			453.9						438.3
Machinery and equipment			1,359.5						1,291.6
Property, gross			1,914.8						1,823.8
Less accumulated depreciation			(928.7)						(868.5)
Property, net			$	986.1					$	955.3

Note 6 — INCOME TAXES

During the three and six months ended June 30, 2025, the Company's effective tax rates of 24.5% and 24.2%, respectively, were above the U.S. federal statutory rate of 21.0% primarily due to the international tax rate differential and withholding tax on foreign earnings. These unfavorable items were partially offset by the favorable impact of foreign permanent items.

During the three and six months ended June 30, 2024, the Company's effective tax rates of 24.9% and 25.1%, respectively, were above the U.S. federal statutory rate of 21.0% primarily due to withholding tax on foreign earnings, tax on global intangible low-taxed income (GILTI), and non-deductible costs. These unfavorable items were partially offset by U.S. research and development credits, a decrease in valuation allowances, and favorable impacts of other foreign tax items.

In December 2024, Avient received a Notice of Deficiency (Notice) from the U.S. Internal Revenue Service (IRS) proposing an adjustment to the 2019 tax year resulting from a disallowed capital loss. The proposed incremental tax associated with the Notice is $23.8 million plus estimated interest of $6.5 million. We contested the Notice by filing a petition in U.S. Tax Court on March 4, 2025. The IRS' answer to Avient's petition included an additional accuracy-related penalty of $4.8 million and is subject to interest. The Company believes that the proposed penalty is also without merit, and we intend to contest the penalty vigorously in U.S. Tax Court. However, there can be no assurance this dispute with the IRS will be resolved favorably. As of June 30, 2025, the Company has not recorded any income tax provision related to this matter, therefore an unfavorable ruling or settlement in U.S. Tax Court would adversely impact our effective tax rate and result in a cash tax payment.

The One Big Beautiful Bill Act (OBBBA) was enacted on July 4, 2025. The OBBBA includes significant tax law changes, such as changes to the limitation on the business interest expense deductions, effective in 2025, and updates to the rules for GILTI and foreign-derived intangible income, effective in 2026. The Company is currently evaluating the OBBBA's impact, however, does not expect it to have a material impact to the current year consolidated financial statements.

8 AVIENT CORPORATION

Note 7 — FINANCING ARRANGEMENTS

Debt consists of the following instruments:

As of June 30, 2025 (in millions)			Principal Amount						Unamortized discount and debt issuance cost						Net Debt						Weighted average interest rate
Senior secured revolving credit facility due 2030			$	—					$	—					$	—					—		%
Senior secured term loan due 2029			670.7						13.2						657.5						5.97		%
7.125% senior notes due 2030			725.0						6.8						718.2						7.125		%
6.250% senior notes due 2031			650.0						8.6						641.4						6.250		%
Other Debt			3.4						—						3.4
Total Debt			2,049.1						28.6						2,020.5
Less short-term and current portion of long-term debt			0.5						—						0.5
Total long-term debt, net of current portion			$	2,048.6					$	28.6					$	2,020.0

As of December 31, 2024 (in millions)			Principal Amount						Unamortized discount and debt issuance cost						Net Debt						Weighted average interest rate
Senior secured revolving credit facility due 2026			$	—					$	—					$	—					—		%
Senior secured term loan due 2029			720.7						15.5						705.2						7.30		%
7.125% senior notes due 2030			725.0						7.5						717.5						7.125		%
6.250% senior notes due 2031			650.0						9.2						640.8						6.250		%
Other Debt			3.5						—						3.5
Total Debt			2,099.2						32.2						2,067.0
Less short-term and current portion of long-term debt			7.7						—						7.7
Total long-term debt, net of current portion			$	2,091.5					$	32.2					$	2,059.3

On March 12, 2025, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the Term Loan Amendment). The Term Loan Amendment reduced the interest rate per annum by 25 basis points, which now is either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 1.75%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 0.75%. The maturity date and other terms and conditions are substantially the same as the terms and conditions under the credit agreement immediately prior to the Term Loan Amendment.

In the second quarter of 2025, the Company made a voluntary prepayment of $50.0 million on its senior secured term loan, which was applied to the principal installments in direct order of maturity. This prepayment was made without penalty or premium.

On June 12, 2025, the Company entered into a revolving credit agreement (the Revolving Credit Agreement) with various financial institutions as lenders, and JPMorgan Chase Bank, N.A., as administrative agent, which replaced our previous credit agreement. The Revolving Credit Agreement provides for a senior secured revolving credit facility of up to $500.0 million, which may be increased by up to $250.0 million, subject to certain conditions. Loans under the Revolving Credit Agreement will mature on June 12, 2030. The Revolving Credit Agreement contains representations and warranties, affirmative covenants, negative covenants and events of default that are substantially similar to those contained in the Company's existing term loan credit agreement.

As of June 30, 2025, we had no borrowings outstanding under the senior secured revolving credit facility.

The agreements governing our senior secured revolving credit facility and our senior secured term loan, and the indentures and credit agreements governing our other debt, contain a number of customary financial and restrictive covenants that, among other things, limit our ability to: sell or otherwise transfer assets, including in a spin-off, incur additional debt or liens, consolidate or merge with any entity or transfer or sell all or substantially all of our assets, pay dividends or make certain other restricted payments, make investments, enter into transactions with affiliates, create dividend or other payment restrictions with respect to subsidiaries, make capital investments and alter the business we conduct. As of June 30, 2025, we were in compliance with all covenants.

The estimated fair value of Avient’s debt instruments at June 30, 2025 and December 31, 2024 was $2,053.8 million and $2,083.3 million, respectively. The fair value of Avient’s debt instruments was estimated using prevailing market interest rates on debt with similar creditworthiness, terms and maturities and represent Level 2 measurements within the fair value hierarchy.

9 AVIENT CORPORATION

Note 8 — DERIVATIVES AND HEDGING

We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. We formally assess, designate and document, as a hedge of an underlying exposure, the qualifying derivative instrument that will be accounted for as an accounting hedge at inception. Additionally, we assess both at inception and at least quarterly thereafter, whether the financial instruments used in the hedging transaction are effective at offsetting changes in either the fair values or cash flows of the underlying exposures. In accordance with ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12), that ongoing assessment will be done qualitatively for highly effective relationships.

As a means of mitigating the impact of currency fluctuations on our Euro investments in foreign entities, we have executed cross-currency swaps, in which we pay fixed-rate interest in Euros and receive fixed-rate interest in U.S. dollars related to our future obligations to exchange euros for U.S. dollars. These cross-currency swaps effectively convert a portion of our U.S. dollar denominated fixed-rate debt to Euro denominated fixed-rate debt.

We currently hold cross-currency swaps with a combined notional amount of €700.0 million maturing in November 2026, €900.0 million maturing in August 2027, €510.5 million maturing in January 2028 and €464.9 million maturing in January 2029. We designated the cross-currency swaps as net investment hedges of our net investment in our European operations under ASU 2017-12 and applied the spot method to these hedges. The changes in fair value of these derivative instruments are recognized within Accumulated Other Comprehensive Income (AOCI) to offset the changes in the values of the net investment being hedged. For the three and six months ended June 30, 2025, losses of $166.3 million and $210.6 million were recognized within translation adjustments in AOCI, net of tax, respectively, compared to gains of $17.1 million and $52.4 million, net of tax, for the three and six months ended June 30, 2024, respectively. Included in Interest expense, net on the Condensed Consolidated Statements of Income is income of $9.1 million and $18.1 million, respectively, for the three and six months ended June 30, 2025, compared to income of $9.7 million and $19.4 million, respectively, for the three and six months ended June 30, 2024, related to interest payments received from counterparties.

All of our derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. We determine the fair value of our derivatives based on valuation methods, which project future cash flows and discount the future amounts to present value using market based observable inputs, including interest rate curves and foreign currency rates.

The fair value of derivative financial instruments recognized in the Condensed Consolidated Balance Sheets is as follows:

(In millions)			Balance Sheet Location						As of June 30, 2025						As of December 31, 2024
Assets
Cross-currency Swaps (Net Investment Hedge)			Other non-current assets						$	—					$	6.1
Liabilities
Cross-currency Swaps (Net Investment Hedge)			Other non-current liabilities						$	380.6					$	104.7

Note 9 — SEGMENT INFORMATION

Avient has two reportable segments: (1) Color, Additives and Inks and (2) Specialty Engineered Materials.

Operating income is the primary segment performance measure that is reported to our chief operating decision maker (CODM), which is the Company's chief executive officer, for purposes of allocating resources and assessing performance. Operating income at the segment level does not include corporate general and administrative expenses that are not allocated to segments, restructuring charges, share-based compensation costs, environmental remediation costs and associated recoveries, asset impairments, acquisition-related charges, mark-to-market adjustments on pension and other post-retirement obligations, and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.

10 AVIENT CORPORATION

Financial information by reportable segment is as follows:

(In millions) Three Months Ended June 30, 2025															Color, Additives and Inks						Specialty Engineered Materials						Corporate						Consolidated Total
Sales															$	538.6					$	329.7					$	(1.8)					$	866.5
Cost of sales															350.6						235.9						2.1						588.6
Selling and administrative expense															97.7						53.6						30.5						181.8
Operating income															$	90.3					$	40.2					$	(34.4)					$	96.1
Interest expense, net																																	(24.7)
Other expense, net																																	(0.5)
Income before income taxes																																	$	70.9

Three Months Ended June 30, 2024															Color, Additives and Inks						Specialty Engineered Materials						Corporate						Consolidated Total
Sales															$	542.0					$	308.1					$	(0.4)					$	849.7
Cost of sales															357.5						213.4						21.2						592.1
Selling and administrative expense															98.4						51.9						34.8						185.1
Operating income															$	86.1					$	42.8					$	(56.4)					$	72.5
Interest expense, net																																	(26.6)
Other expense, net																																	(0.9)
Income before income taxes																																	$	45.0

Six Months Ended June 30, 2025															Color, Additives and Inks						Specialty Engineered Materials						Corporate						Consolidated Total
Sales															$	1,058.3					$	638.1					$	(3.3)					$	1,693.1
Cost of sales															697.2						446.5						8.3						1,152.0
Selling and administrative expense															192.2						104.3						147.8						444.3
Operating income															$	168.9					$	87.3					$	(159.4)					$	96.8
Interest expense, net																																	(51.6)
Other expense																																	(0.9)
Income before income taxes																																	$	44.3

Six Months Ended June 30, 2024															Color, Additives and Inks						Specialty Engineered Materials						Corporate						Consolidated Total
Sales															$	1,057.3					$	622.5					$	(1.1)					$	1,678.7
Cost of sales															701.6						420.8						20.5						1,142.9
Selling and administrative expense															194.8						105.5						69.0						369.3
Operating income															$	160.9					$	96.2					$	(90.6)					$	166.5
Interest expense, net																																	(53.2)
Other expense																																	(1.8)
Income before income taxes																																	$	111.5

11 AVIENT CORPORATION

			Three Months Ended June 30,												Six Months Ended June 30,
			2025						2024						2025						2024
Depreciation and amortization:
Color, Additives and Inks			$	22.4					$	21.8					$	44.1					$	43.7
Specialty Engineered Materials			22.4						20.8						43.9						40.4
Corporate			1.8						2.3						3.9						5.1
Depreciation and amortization			$	46.6					$	44.9					$	91.9					$	89.2
Capital expenditures:
Color, Additives and Inks			$	8.4					$	7.1					$	13.3					$	11.0
Specialty Engineered Materials			14.7						8.9						21.5						14.2
Corporate			3.9						15.4						4.7						30.6
Capital expenditures			$	27.0					$	31.4					$	39.5					$	55.8

			Total Assets
(In millions)			As of June 30, 2025						As of December 31, 2024
Color, Additives and Inks			$	2,735.3					$	2,574.2
Specialty Engineered Materials			2,602.3						2,452.3
Corporate			795.7						784.6
Total assets			$	6,133.3					$	5,811.1

Note 10 — COMMITMENTS AND CONTINGENCIES

We have been notified by federal and state environmental agencies and by private parties that we may be a potentially responsible party (PRP) in connection with the environmental investigation and remediation of certain sites. While government agencies frequently assert that PRPs are jointly and severally liable at these sites, in our experience, the interim and final allocations of liability costs are generally made based on the relative contribution of waste. We may also initiate corrective and preventive environmental projects of our own to support safe and lawful activities at our operations. We believe that compliance with current governmental regulations at all levels will not have a material adverse effect on our financial position, results of operations or cash flows.

In September 2007, the United States District Court for the Western District of Kentucky (Court) in the case of Westlake Vinyls, Inc. v. Goodrich Corporation, et al., held that Avient must pay the remediation costs at the former Goodrich Corporation Calvert City facility (now largely owned and operated by Westlake Vinyls, Inc. (Westlake Vinyls)), together with certain defense costs of Goodrich Corporation. The rulings also provided that Avient can seek indemnification for contamination attributable to Westlake Vinyls. Following the rulings, the parties to the litigation agreed to settle all claims regarding past environmental costs incurred at the site. The settlement agreement provides a mechanism to pursue allocation of future remediation costs at the Calvert City site to Westlake Vinyls.

The environmental obligation at the site arose as a result of an agreement between The B.F. Goodrich Company (n/k/a Goodrich Corporation) and our predecessor, The Geon Company, at the time of the initial public offering in 1993. Under the agreement, The Geon Company agreed to indemnify Goodrich Corporation for certain environmental costs at the site. Neither Avient nor The Geon Company ever operated the facility.

Since 2009, Avient, along with respondents Westlake Vinyls and Goodrich Corporation, has worked with the United States Environmental Protection Agency (USEPA) to address the remedial activities at the site. The USEPA issued its Record of Decision (ROD) in September 2018. In April 2019, the respondents signed an Administrative Settlement Agreement and Order on Consent with the USEPA to conduct the remedial actions at the site. In February 2020, three companies signed the agreed Consent Decree and remedial action Work Plan, which received Federal Court approval in January 2021.

The largest component of remedial action at Calvert City is construction of a barrier wall around the site. Construction of the initial barrier wall section began in 2024 and was completed in the first quarter of 2025. The remaining wall designs and construction are expected to be completed in phases through 2028. As the Company completes further design work and begins construction on the remaining sections of the barrier wall and other remedial components, the Company will update its accrual, which was $133.3 million as of June 30, 2025, for any new information as it becomes available.

12 AVIENT CORPORATION

Total environmental accruals of $141.3 million and $146.0 million are reflected within Accrued expenses and other current liabilities and Other non-current liabilities in our Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024, respectively. These undiscounted accruals represent our best estimate of probable future costs that we can reasonably estimate, based upon currently available information and technology and how the remedy will be implemented. It is reasonably possible that we could incur additional costs in excess of the amount accrued, which could be material to our Condensed Consolidated Statements of Income. However, such additional costs cannot be currently estimated as they are dependent upon the results of future testing and findings during the execution of remedial design and remedial action, changes in the Calvert City construction timeline, changes in regulations, technology development, new information, newly discovered conditions and other factors that are not currently known.

During the three and six months ended June 30, 2025, Avient recognized costs of $1.8 million and $6.7 million, primarily associated with the ongoing remedial design and remedial action at Calvert City, compared to costs of $21.8 million and $25.8 million recognized during the three and six months ended June 30, 2024. These costs are recognized in Cost of Sales within the Condensed Consolidated Statements of Income.

We received $34.0 million of cash associated with Calvert City insurance recoveries in the first quarter of 2025. The associated gain was recognized in the fourth quarter of 2024. Further insurance recoveries, if any, related to remedial activities at the Calvert City site are expected to be immaterial. During the three and six months ended June 30, 2025, Avient recognized gains related to insurance and other environmental recoveries of $0.6 million and $1.3 million, respectively, unrelated to Calvert City. These gains are included in Cost of sales within the Consolidated Statements of Income.

Avient is subject to a broad range of claims, administrative and legal proceedings such as lawsuits that relate to contractual allegations, tax audits, product claims, personal injuries, and employment related matters. Although it is not possible to predict with certainty the outcome or cost of these matters, the Company believes our current reserves are appropriate and these matters will not have a material adverse effect on the condensed consolidated financial statements.

13 AVIENT CORPORATION

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Our Business

We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered materials, performance fibers, advanced composites, and color and additive solutions. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and silicone colorants. Headquartered in Avon Lake, Ohio, we have manufacturing sites, research and development facilities, design centers and warehouses around the globe. We provide value to our customers through our ability to link our knowledge of polymers and materials science with our manufacturing and supply chain capabilities to provide value-added solutions to designers, assemblers and processors of materials. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.

Results of Operations — The three and six months ended June 30, 2025 compared to the three and six months ended June 30, 2024:

			Three Months Ended June 30,												Variances — Favorable (Unfavorable)												Six Months Ended June 30,												Variances — Favorable (Unfavorable)
(Dollars in millions, except per share data)			2025						2024						Change						% Change						2025						2024						Change						% Change
Sales			$	866.5					$	849.7					$	16.8					2.0		%				$	1,693.1					$	1,678.7					$	14.4					0.9		%
Cost of sales			588.6						592.1						3.5						0.6		%				1,152.0						1,142.9						(9.1)						(0.8)		%
Gross margin			277.9						257.6						20.3						7.9		%				541.1						535.8						5.3						1.0		%
Selling and administrative expense			181.8						185.1						3.3						1.8		%				444.3						369.3						(75.0)						(20.3)		%
Operating income			96.1						72.5						23.6						32.6		%				96.8						166.5						(69.7)						(41.9)		%
Interest expense, net			(24.7)						(26.6)						1.9						7.1		%				(51.6)						(53.2)						1.6						3.0		%
Other expense, net			(0.5)						(0.9)						0.4						nm						(0.9)						(1.8)						0.9						nm
Income before income taxes			70.9						45.0						25.9						57.6		%				44.3						111.5						(67.2)						(60.3)		%
Income tax expense			(17.4)						(11.2)						(6.2)						(55.4)		%				(10.7)						(28.0)						17.3						61.8		%
Net income			53.5						33.8						19.7						58.3		%				33.6						83.5						(49.9)						(59.8)		%
Net income attributable to noncontrolling interests			(0.9)						(0.2)						(0.7)						nm						(1.2)						(0.5)						(0.7)						nm
Net income attributable to Avient common shareholders			$	52.6					$	33.6					$	19.0					56.5		%				$	32.4					$	83.0					$	(50.6)					(61.0)		%
Earnings per share attributable to Avient common shareholders - Basic:			$	0.57					$	0.37																	$	0.35					$	0.91
Earnings per share attributable to Avient common shareholders - Diluted:			$	0.57					$	0.36																	$	0.35					$	0.90

nm - not meaningful

Sales

Sales increased $16.8 million, or 2.0%, in the three months ended June 30, 2025 compared to the three months ended June 30, 2024. Favorable foreign currency impacts were 1.4%, while sales, excluding the impacts of foreign exchange, increased 0.6%. The sales increase was primarily within the defense and healthcare end markets, partially offset by declines in the consumer and industrial end markets.

Sales increased $14.4 million, or 0.9%, for the six months ended June 30, 2025 compared to the six months ended June 30, 2024. Unfavorable foreign currency impacts were 0.3%, while sales, excluding the impacts of foreign exchange, increased 1.2%. The sales increase was primarily within the packaging, defense and healthcare end markets, partially offset by declines in the consumer end market.

Gross Margin

Gross margin as a percentage of sales was 32.1% for the three months ended June 30, 2025 compared to 30.3% for the three months ended June 30, 2024. This increase was driven primarily by lower environmental remediation charges of $20.6 million, net of recoveries, partially offset by higher restructuring charges of $2.8 million.

14 AVIENT CORPORATION

Gross margin as a percentage of sales was 32.0% for the six months ended June 30, 2025 compared to 31.9% for the six months ended June 30, 2024. This increase was driven primarily by lower environmental remediation charges of $21.0 million, net of recoveries, partially offset by higher restructuring charges of $10.5 million.

Selling and administrative expense

Selling and administrative expense decreased $3.3 million for the three months ended June 30, 2025, primarily driven by lower compensation cost. Selling and administrative expense increased $75.0 million for the six months ended June 30, 2025, primarily driven by an impairment charge of $71.6 million associated with the Company's decision to cease development of the cloud-based enterprise resource planning system, S/4HANA, and charges of $14.7 million associated with unpaid contractual obligations for hosting fees. These charges were partially offset by lower compensation cost.

Interest expense, net

Interest expense, net decreased $1.9 million and $1.6 million for the three and six months ended June 30, 2025, respectively, primarily driven by the benefit of reduced interest rates resulting from previous refinancing activity.

Income taxes

During the three months ended June 30, 2025, the Company’s effective tax rate was 24.5% compared to 24.9% in the three months ended June 30, 2024. The lower effective tax rate for the three months ended June 30, 2025 was primarily driven by a decrease in the tax on global intangible low-taxed income (GILTI) partially offset by a reduction in favorable foreign permanent items. During the six months ended June 30, 2025, the Company's effective tax rate was 24.2% compared to 25.1% in the six months ended June 30, 2024. The lower effective tax rate for the six months ended June 30, 2025 was primarily driven by a decrease in GILTI tax and increased favorable permanent items. Partially offsetting these benefits was an increase in valuation allowances.

Refer to Note 6, Income Taxes, for further details.

SEGMENT INFORMATION

Avient has two reportable segments: (1) Color, Additives and Inks; and (2) Specialty Engineered Materials.

Operating income is the primary segment performance measure that is reported to our chief operating decision maker (CODM), which is the Company's chief executive officer, for purposes of allocating resources and assessing performance. Operating income at the segment level does not include corporate general and administrative expenses that are not allocated to segments, restructuring charges, share-based compensation costs, environmental remediation costs and associated recoveries, asset impairments, acquisition-related charges, mark-to-market adjustments on pension and other post-retirement obligations, and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.

Sales and Operating Income — The three and six months ended June 30, 2025 compared to the three and six months ended June 30, 2024: 

			Three Months Ended June 30,												Variances — Favorable (Unfavorable)												Six Months Ended June 30,												Variances — Favorable (Unfavorable)
(Dollars in millions)			2025						2024						Change						%  Change						2025						2024						Change						%  Change
Sales:
Color, Additives and Inks			$	538.6					$	542.0					$	(3.4)					(0.6)		%				$	1,058.3					$	1,057.3					$	1.0					0.1		%
Specialty Engineered Materials			329.7						308.1						21.6						7.0		%				638.1						622.5						15.6						2.5		%
Corporate			(1.8)						(0.4)						(1.4)						nm						(3.3)						(1.1)						(2.2)						nm
Total sales			$	866.5					$	849.7					$	16.8					2.0		%				$	1,693.1					$	1,678.7					$	14.4					0.9		%
Operating income:
Color, Additives and Inks			$	90.3					$	86.1					$	4.2					4.9		%				$	168.9					$	160.9					$	8.0					5.0		%
Specialty Engineered Materials			40.2						42.8						(2.6)						(6.1)		%				87.3						96.2						(8.9)						(9.3)		%
Corporate			(34.4)						(56.4)						22.0						39.0		%				(159.4)						(90.6)						(68.8)						(75.9)		%
Total operating income			$	96.1					$	72.5					$	23.6					32.6		%				$	96.8					$	166.5					$	(69.7)					(41.9)		%

15 AVIENT CORPORATION

Color, Additives and Inks

Sales decreased $3.4 million, or 0.6%, in the three months ended June 30, 2025 compared to the three months ended June 30, 2024. Favorable foreign currency impacts were 1.4%, while sales, excluding the impacts of foreign exchange, decreased 2.0%. The sales decrease was primarily within the consumer and transportation end markets, partially offset by sales increases within the healthcare end market.

Sales increased $1.0 million, or 0.1%, in the six months ended June 30, 2025 compared to the six months ended June 30, 2024. Unfavorable foreign currency impacts were 0.5%, while sales, excluding the impacts of foreign exchange, increased 0.6%. The sales increase was primarily within the packaging and healthcare end markets, partially offset by declines in the consumer and transportation end markets.

Operating income increased $4.2 million and $8.0 million for the three and six months ended June 30, 2025, respectively, primarily driven by improved mix and cost savings from productivity and restructuring actions.

Specialty Engineered Materials

Sales increased $21.6 million, or 7.0%, in the three months ended June 30, 2025 compared to the three months ended June 30, 2024. Favorable foreign currency impacts were 1.3%, while sales, excluding the impacts of foreign exchange, increased 5.7%. The sales increase was primarily within the defense and healthcare end markets, partially offset by declines in the consumer end market.

Sales increased $15.6 million, or 2.5%, in the six months ended June 30, 2025 compared to the six months ended June 30, 2024. Unfavorable foreign currency impacts were 0.1%, while sales, excluding the impacts of foreign exchange, increased 2.6%. The sales increase was primarily within the defense and healthcare end markets, partially offset by declines in the consumer and industrial end markets.

Operating income decreased $2.6 million and $8.9 million for the three and six months ended June 30, 2025, respectively, driven by higher operating costs, primarily associated with planned maintenance, and investments in the Company's growth vectors.

Corporate

Corporate costs decreased $22.0 million for the three months ended June 30, 2025, primarily driven by lower environmental costs of $20.6 million, net of recoveries.

Corporate costs increased $68.8 million for the six months ended June 30, 2025, primarily driven by an impairment charge of $71.6 million associated with the Company's decision to cease development of the cloud-based enterprise resource planning system, S/4HANA, charges of $14.7 million associated with unpaid contractual obligations for hosting fees, and higher restructuring costs of $17.3 million. Partially offsetting these charges was lower environmental remediation charges of $21.0 million, net of recoveries, and lower compensation cost.

Liquidity and Capital Resources

Our objective is to finance our business through operating cash flow and an appropriate mix of debt and equity. By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. We may from time to time seek to retire or purchase our outstanding debt with cash and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. We may also seek to repurchase our outstanding common shares. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved have been and may continue to be material.

The following table summarizes our liquidity as of June 30, 2025 and December 31, 2024:

(In millions)			As of June 30, 2025						As of December 31, 2024
Cash and cash equivalents			$	474.5					$	544.5
Revolving credit availability			487.1						211.4
Liquidity			$	961.6					$	755.9

As of June 30, 2025, approximately 73% of the Company’s cash and cash equivalents resided outside the United States.

16 AVIENT CORPORATION

Expected sources of cash needed to satisfy cash requirements for 2025 include our cash on hand, cash from operations and available liquidity under our revolving credit facility, if necessary. We believe that these sources will also provide sufficient liquidity to satisfy our expected uses of cash for at least the next twelve months and the foreseeable future thereafter. Expected uses of cash for 2025 include debt payments, interest payments, cash taxes, dividend payments, environmental remediation payments and capital expenditures.

Cash Flows

The following describes the significant components of cash flows from operating, investing and financing activities for the six months ended June 30, 2025 and 2024.

Operating Activities — Net cash provided by operating activities decreased $1.4 million during the six months ended June 30, 2025 compared to the six months ended June 30, 2024, driven primarily by higher incentive compensation payments and increased working capital, partially offset by insurance proceeds of $34.0 million for previously incurred losses at the Calvert City site.

Investing Activities — Net cash used by investing activities during the six months ended June 30, 2025 and 2024 of $39.5 million and $54.5 million, respectively, primarily reflects the impact of capital expenditures.

Financing Activities — Net cash used by financing activities for the six months ended June 30, 2025 of $106.4 million primarily reflects payment on long-term borrowings of $50.2 million and $49.4 million of dividends paid.

Net cash used by financing activities for the six months ended June 30, 2024 of $54.8 million primarily reflects $47.0 million of dividends paid.

Debt

As of June 30, 2025, aggregate maturities of the principal amount of debt for the current year, next four years and thereafter, are as follows:

(In millions)
2025						$	0.3
2026						0.5
2027						0.4
2028						0.4
2029						671.1
Thereafter						1,376.4
Aggregate maturities						$	2,049.1

On March 12, 2025, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the Term Loan Amendment). The Term Loan Amendment reduced the interest rate per annum by 25 basis points, which now is either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 1.75%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 0.75%. The maturity date and other terms and conditions are substantially the same as the terms and conditions under the credit agreement immediately prior to the Term Loan Amendment.

In the second quarter of 2025, the Company made a voluntary prepayment of $50.0 million on its senior secured term loan, which was applied to the principal installments in direct order of maturity. This prepayment was made without penalty or premium.

On June 12, 2025, the Company entered into a revolving credit agreement (the Revolving Credit Agreement) with various financial institutions as lenders, and JPMorgan Chase Bank, N.A., as administrative agent, which replaced our previous credit agreement. The Revolving Credit Agreement provides for a senior secured revolving credit facility of up to $500.0 million, which may be increased by up to $250.0 million, subject to certain conditions. Loans under the Revolving Credit Agreement will mature on June 12, 2030. The Revolving Credit Agreement contains representations and warranties, affirmative covenants, negative covenants and events of default that are substantially similar to those contained in the Company's existing term loan credit agreement.

As of June 30, 2025, we were in compliance with all financial and restrictive covenants pertaining to our debt. For additional information regarding our debt, please see Note 7, Financing Arrangements, to the accompanying condensed consolidated financial statements.

17 AVIENT CORPORATION

Derivatives and Hedging

We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. For additional information regarding our derivative instruments, please see Note 8, Derivatives and Hedging, to the accompanying condensed consolidated financial statements.

Material Cash Requirements

We have future obligations under various contracts relating to debt and interest payments, operating leases, pension and post-retirement benefit plans, purchase obligations and environmental remediation obligations. During the six months ended June 30, 2025, we refinanced our senior secured term loan, which reduced the interest rate per annum by 25 basis points, and made a voluntary prepayment of $50.0 million, refer to Note 9, Financing Arrangements. There were no other material changes to these obligations as reported in our Annual Report on Form 10-K for the year ended December 31, 2024.

18 AVIENT CORPORATION

CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS

In this Quarterly Report on Form 10-Q, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:

•disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;

•the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;

•disruptions or inefficiencies in our supply chain, logistics, or operations;

•changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;

•fluctuations in raw material prices, quality and supply, and in energy prices and supply;

•demand for our products and services;

•production outages or material costs associated with scheduled or unscheduled maintenance programs;

•unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;

•our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;

•information systems failures and cyberattacks;

•our ability to service our indebtedness and restrictions on our current and future operations due to our indebtedness;

•amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;

•other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, tariffs and any recessionary conditions; and

•other factors described in our Annual Report on Form 10-K for the year ended December 31, 2024 under Item 1A, “Risk Factors.”

We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.

19 AVIENT CORPORATION

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to exposures to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2024.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures

Avient’s management, under the supervision of and with the participation of its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of the design and operation of Avient’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. Based upon this evaluation, Avient’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report, its disclosure controls and procedures were effective.

Changes in internal control over financial reporting

There were no changes in Avient’s internal control over financial reporting during the quarter ended June 30, 2025 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Information regarding certain legal proceedings can be found in Note 10, Commitments and Contingencies, to the accompanying condensed consolidated financial statements and is incorporated by reference herein.

ITEM 1A. RISK FACTORS

We face a number of risks that could adversely affect our business, results of operations, financial position or cash flows. A discussion of our risk factors can be found in Item 1A, Risk factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Except for below, as of June 30, 2025, there have been no material changes to the risk factors that were previously disclosed.

Changes to foreign trade policy, including new or increased tariffs and changing import/export regulations, could adversely affect our operating results, and the impacts could be material.

Changes in foreign trade policy, regulatory or economic conditions or in laws governing international trade could materially adversely affect our business. The U.S. has instituted certain changes, and may propose additional changes, in trade policies that include the negotiation or termination of trade agreements, the imposition of higher tariffs on goods exported from the U.S. or imported into the U.S., and other government regulations affecting trade between the U.S. and other countries (such as Canada, Mexico, China, and the European Union) where we conduct our business. Global trade disruption or significant introduction of trade barriers, together with any future downturns in the global economy, could further materially and adversely affect our financial performance.

As a result of policy changes and government proposals, there may be greater restrictions and economic disincentives on international trade. The new tariffs and other changes in U.S. trade policy have triggered retaliatory actions by affected countries, and foreign governments have instituted or are considering imposing tariffs and trade sanctions. Such changes have the potential to adversely impact the global economy, our industry and the global demand for our products, and as a result, could have a negative impact on our business, financial condition and results of operations.

20 AVIENT CORPORATION

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The table below sets forth information regarding the repurchase of shares of our common shares during the period indicated.

Period			Total Number of Shares Purchased						Weighted Average Price Paid Per Share						Total Number of Shares Purchased as Part of Publicly Announced Program						Maximum Number of Shares that May Yet be Purchased Under the Program (1)
April 1 to April 30			—						$	—					—						4,957,472
May 1 to May 31			—						—						—						4,957,472
June 1 to June 30			—						—						—						4,957,472
Total			—						$	—					—

(1) Our Board of Directors approved a common share repurchase program authorizing Avient to purchase its common shares in August 2008, which share repurchase authorization has been subsequently increased from time to time. On December 9, 2020, we announced that we would increase our share buyback by an additional 5.0 million shares. As of June 30, 2025, approximately 5.0 million shares remained available for purchase under these authorizations, which have no expiration. Purchases of common shares may be made by open market purchases or privately negotiated transactions and may be made pursuant to Rule 10b5-1 plans and accelerated share repurchases.

ITEM 5. OTHER INFORMATION

Trading Arrangements

None of the Company's directors or officers (as defined in Rule 16a-1(f) promulgated under the Securities Exchange Act of 1934) adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the Company's fiscal quarter ended June 30, 2025.

21 AVIENT CORPORATION

ITEM 6. EXHIBITS

EXHIBIT INDEX

Exhibit No.						Exhibit Description
3.1						Amended and Restated Articles of Incorporation of Avient Corporation (as amended through June 30, 2020) (incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, SEC File No. 1-16091)
3.2						Avient Corporation Regulations (amended and restated effective May 11, 2023) (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed May 16, 2023, SEC File No. 1-16091)
10.1†						Revolving Credit Agreement, dated as of June 12, 2025, by and among Avient Corporation, JPMorgan Chase Bank, N.A., as administrative agent, and the various lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed June 16, 2025, SEC File No. 1-16091)
31.1**						Certification of Ashish K. Khandpur, Chairman, President and Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2**						Certification of Jamie A. Beggs, Senior Vice President and Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*						Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Ashish K. Khandpur, Chairman, President and Chief Executive Officer
32.2*						Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Jamie A. Beggs, Senior Vice President and Chief Financial Officer
101.INS						Inline XBRL Instance Document
101.SCH						Inline XBRL Taxonomy Extension Schema Document
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
†						Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request.
*						Furnished herewith.
**						Filed herewith.

22 AVIENT CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

August 1, 2025			AVIENT CORPORATION
			/s/ Jamie A. Beggs
			Jamie A. Beggs Senior Vice President and Chief Financial Officer

23 AVIENT CORPORATION

FAQ

How did Avient's (AVNT) Q2-25 earnings compare to last year?

Diluted EPS rose to $0.57 from $0.36, a 56% year-over-year increase.

What caused the large impairment charge in 2025?

Avient recorded a $71.6 million non-cash impairment after deciding to discontinue its S/4HANA cloud ERP implementation.

How much debt does AVNT have after the June 2025 quarter?

Total debt stands at $2.05 billion with no borrowings under the new $500 million revolver.

What are Avient's environmental obligations at Calvert City?

The company has accrued $133.3 million for the barrier-wall remediation, part of total environmental accruals of $141.3 million.

Did the credit agreement change during the quarter?

Yes, Avient refinanced its term loan (-25 bp spread) and entered a new $500 million revolver maturing 2030.

What is the status of the IRS tax notice?

Avient is contesting a proposed $23.8 million tax adjustment (plus interest & penalties) in U.S. Tax Court; no provision has been booked.